A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Lunesta news





Lunesta Blog News Updates

6/12/2014
02:46 | Author: Evan Martin

Xanax information
Lunesta Blog News Updates

Read the latest news & information concerning Lunesta.

WEDNESDAY, April 3 – A new class of sleep medications appears to help people fall asleep without causing grogginess the next day, researchers say. More than 30 million Americans struggle to get a good night's sleep, and about. Uslaner is director of In Vivo Pharmacology at Merck & Co., which funded the study. Read more. Food and Drug Administration (FDA). "We've shown that these compounds improve sleep at doses that don't impact cognition," said Jason Uslaner, lead author of a study published in the April 3 issue of Science Translational Medicine.

Comments (1)Read more



FDA lowers starting dose of sleep drug Lunesta over safety Fox News

4/11/2014
04:52 | Author: Evan Martin

Xanax information
FDA lowers starting dose of sleep drug Lunesta over safety Fox News

U.S. health regulators on Thursday said they required a label change for the sleep drug Lunesta to cut the recommended starting dose over.

Advertisement. The study found that the higher doses can cause impairment to driving skills, memory and coordination as long as 11 hours after the drug is taken, with little awareness of the impairment on the part of the patient.

All market data delayed 20 minutes. Privacy - Terms - FAQ. 2014 FOX News Network, LLC. This material may not be published, broadcast, rewritten, or redistributed.

The label change decision was made after a study showed Lunesta 3 mg was associated with severe next-morning psychomotor and memory impairment in both men and women.

"To help ensure patient safety, health care professionals should prescribe, and patients should take, the lowest dose of a sleep medicine that effectively treats their insomnia," Ellis Unger, of the FDA's Center for Drug Evaluation and Research, said in a statement.

ADVERTISEMENT ADVERTISEMENT. The Food and Drug Administration said the starting dose for the drug taken at bedtime for both men and women should be the lowest 1 milligram dose, down from the previous 2 mg recommended starting dose. The agency said the drug could remain in a patient's system long enough to impair activities such as driving, even if the person feels fully awake.

Weekly news and features that matter the most to your well-being More Advertisement.

Lunesta is sold by the Sunovion Pharmaceuticals unit of Japanese drugmaker Dainippon Sumitomo Pharma Co.

health regulators on Thursday said they required a label change for the sleep drug Lunesta to cut the recommended starting dose over concerns it could impair alertness in some people the following morning. U.S.

Keep up with all the 2014 races in.

See the latest updates on the hottest midterm races from Fox News.

The 1 mg dose can be increased to 2 mg or 3 mg if needed, but the higher doses are more likely to result in next-day impairment, the agency said.

Sign in to comment!

Comments (0)

Starting Dose of Sleep Drug Lunesta Should Be Cut in Half, FDA

12/20/2014
04:22 | Author: Caitlin White

Xanax information
Starting Dose of Sleep Drug Lunesta Should Be Cut in Half, FDA

FRIDAY, May 16, 2014 (HealthDay News) — Some users of the popular sleep medicine Lunesta remain too drowsy for safety during the day.

Next-day drowsiness is a common side effect of all insomnia drugs, the FDA noted.

The recommended starting dose of Lunesta — taken at bedtime — has been reduced from 2 milligrams (mg) to 1 mg for both women and men, which means that less of the drug will remain in the body the next morning.

Ellis Unger, director of the Office of Drug Evaluation I in the FDA’s Center for Drug Evaluation and Research, said in the FDA news release. “To help ensure patient safety, health care professionals should prescribe, and patients should take, the lowest dose of a sleep medicine that effectively treats their insomnia,” Dr.

See the Terms of Service and Privacy Policy ( Your California Privacy Rights ) for more information.

Comments (3)Read more

FDA Cuts Recommended Dosage of Lunesta Video - ABC News

10/19/2014
02:24 | Author: Devin Garcia

Xanax information
FDA Cuts Recommended Dosage of Lunesta Video - ABC News

A warning about the popular sleeping aid lunesta. And its generic form. Taken by early 1 million Americans. The fda is cutting the.

Hannah Graham Search Now Called Death Investigation.

Woman Trapped in Chimney of Man She Met Online.

Virginia Serial Killer Caught?

Screen For Ebola At All Airports?. Should the U.S.

Convicted Killer Jodi Arias' Eyewear Is Up for Auction.

Phoenix Hammer Murder Trial Mirrors Jodi Arias.

Alleged Indiana Serial Killer May Be in Custody.

Woman's Serial Killer Claims Can't Be Verified: Investigators.

Jodi Arias Trial Highlights.

Can the CDC Win Back Public Trust?

Washington Man Freed From Chimney.

Are Our Seaports Safe From Ebola?

Woman Describes Chilling Encounter With Cop-Killer Suspect.

Serial Killer Suspect Says Spree Dates Back 2 Decades.

Firefighters Save Teen Stuck in Chimney.

Cancel Set.

Comments (0)

FDA lowers starting dose of sleeping aid Lunesta CTV News

8/18/2014
12:10 | Author: Caitlin White

Xanax information
FDA lowers starting dose of sleeping aid Lunesta CTV News

Federal health officials are lowering the starting dose of the popular sleeping aid drug Lunesta, due to risks of morning drowsiness that can.

Lunesta manufacturer Sunovion Pharmaceuticals will lower the starting dose of the tablet to 1 milligram from currently available 2 milligrams. Patients can increase their dose to 2 or 3 milligrams, but should keep in mind that higher doses are more likely to cause next-day impairment, according to the FDA statement.

Lunesta, launched in 2005, is designed to be taken before bed to help patients with insomnia fall asleep and stay asleep for up to 7 hours.

Patients are often unaware that they are still drowsy the morning after, according to the FDA.

Comments (5)Read more